United Therapeutics (UTHR) Ranks 1st in Renaissance Technologies 2026 List

AI Summary

United Therapeutics Corporation (UTHR) is ranked 1st on Renaissance Technologies' list of top stocks for 2026. The fund disclosed its initial stake of 261,000 shares in UTHR in Q4 2010. As of Q1 2026, Renaissance owns nearly 1.8 million shares, a decrease of over 6% from Q4 2025. The company is preparing major NDA submissions to the FDA for Tyvaso, which aims to be the first inhaled anti-fibrotic treatment for Idiopathic Pulmonary Fibrosis, following positive data from its TETON studies.